Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-003880
Filing Date
2025-05-20
Accepted
2025-05-20 16:00:40
Documents
51
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 mosaic_i10q-033125.htm   iXBRL 10-Q 402922
2 CERTIFICATION mosaic_ex3101.htm EX-31.1 8216
3 CERTIFICATION mosaic_ex3102.htm EX-31.2 8231
4 CERTIFICATION mosaic_ex3201.htm EX-32.1 4997
5 CERTIFICATION mosaic_ex3202.htm EX-32.2 5192
  Complete submission text file 0001683168-25-003880.txt   2389919

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cpmv-20250331.xsd EX-101.SCH 24403
7 XBRL CALCULATION FILE cpmv-20250331_cal.xml EX-101.CAL 30999
8 XBRL DEFINITION FILE cpmv-20250331_def.xml EX-101.DEF 105975
9 XBRL LABEL FILE cpmv-20250331_lab.xml EX-101.LAB 173022
10 XBRL PRESENTATION FILE cpmv-20250331_pre.xml EX-101.PRE 155895
53 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_i10q-033125_htm.xml XML 213954
Mailing Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646
Business Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

EIN.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22182 | Film No.: 25968584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)